Eli Lilly (NYSE: LLY) received some great news from regulators last week: Its Alzheimer’s treatment obtained the green light from the Food and Drug Administration (FDA)....
InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. Federal Trade Commission Chair Lina Khan Getty Images The Federal...
(Bloomberg) — Eli Lilly & Co. agreed to buy U.S. gut-drug maker Morphic Holding Inc. for about $3.2 billion, plowing some of the proceeds from obesity...
The Food and Drug Administration approved a new Alzheimer’s treatment called donanemab on Tuesday, clearing the way for the third addition to a new class of...
The Food and Drug Administration approved a new Alzheimer’s treatment called donanemab on Tuesday, clearing the way for the third addition to a new class of...
(Bloomberg) — Novo Nordisk A/S and Eli Lilly & Co. shares fell Tuesday after US President Joe Biden demanded price cuts on their blockbuster weight loss...
Skyrocketing sales for weight loss drugs known as GLP-1s, first made popular via the diabetes treatment Ozempic, have had ripple effects across the global economy. As...
Zealand Pharma stock is up 17%. Image: NurPhoto / Contributor (Getty Images) Zealand Pharma’s stock initially jumped 23% early Friday, after the company announced topline results...
In another ripple effect on the economy, Ozempic and other weight loss drugs are boosting sales of smaller-sized clothes. Apple AirPods and Watches could soon see...
The 10-year Treasury yield has dropped to a key level. If it’s in for a longer slide, a few stocks would benefit the most. The yield...